• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨形态发生蛋白在成釉细胞瘤骨缺损再生中与自体骨的疗效比较。系统评价。

Efficacy of bone morphogenetic protein in comparison with autogenous bone in regeneration of ameloblastoma bone defects. A systematic review.

机构信息

School of Medicine and Health Sciences Campus de Bellvitge. University of Barcelona C/ Feixa Llarga s/n; Pavelló Govern, 2ª planta, Despatx 2.9 08907 - L'Hospitalet de Llobregat (Barcelona), Spain

出版信息

Med Oral Patol Oral Cir Bucal. 2024 Nov 1;29(6):e782-e790. doi: 10.4317/medoral.26729.

DOI:10.4317/medoral.26729
PMID:39396143
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11584972/
Abstract

BACKGROUND

To evaluate the evidence comparing bone morphogenetic proteins (BMPs) and autogenous bone grafts (ABGs) for regenerating bone defects from ameloblastoma.

MATERIAL AND METHODS

An electronic search was performed in PubMed and Scopus from October to December 2023, supplemented by manual searches and review of relevant study reference lists. Cohen's kappa was calculated to assess the interrater reliability between two independent investigators. The methodological quality and risk of bias of the selected articles was assessed using the JBI checklist for case series and the NOS for observational studies.

RESULTS

Nine studies met the inclusion criteria and were selected for the qualitative synthesis. Cohen's kappa (κ) value resulted in 98.21% agreement. A total of 229 participants were included. The BMPs were evaluated in five studies, and four evaluated the ABGs. The BMPs has been tested in 25.76% of the patients, while ABGs were studied in 74.24%. In order to evaluate the final result of regeneration, all the studies based their analysis on postoperative questionnaires, radiographical (CBCT and/or panoramic) and/or clinical examination. The results showed a higher regeneration success rate in the studies where the BMPs was used.

CONCLUSIONS

Considering the limitations of the studies and the review, it has been shown that BMPs may yield favorable outcomes in terms of bone regeneration, as compared with ABGs.

摘要

背景

评估比较骨形态发生蛋白(BMPs)和自体骨移植物(ABGs)用于再生造釉细胞瘤骨缺损的证据。

材料和方法

2023 年 10 月至 12 月,我们在 PubMed 和 Scopus 上进行了电子检索,并辅以手动检索和相关研究参考文献列表的审查。使用 Cohen's kappa 评估两位独立研究者之间的评分者间可靠性。使用 JBI 病例系列检查表和 NOS 对观察性研究评估选定文章的方法学质量和偏倚风险。

结果

符合纳入标准的 9 项研究被选入定性综合分析。Cohen's kappa(κ)值的一致性为 98.21%。共有 229 名参与者入选。五项研究评估了 BMPs,四项研究评估了 ABGs。BMPs 在 25.76%的患者中进行了测试,而 ABGs 在 74.24%的患者中进行了研究。为了评估再生的最终结果,所有研究都基于术后问卷调查、影像学(CBCT 和/或全景)和/或临床检查来进行分析。结果表明,在使用 BMPs 的研究中,再生成功率更高。

结论

考虑到研究和综述的局限性,BMPs 可能在骨再生方面优于 ABGs,从而产生更好的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df38/11584972/ee9a757bd24e/medoral-29-e782-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df38/11584972/ee9a757bd24e/medoral-29-e782-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df38/11584972/ee9a757bd24e/medoral-29-e782-g001.jpg

相似文献

1
Efficacy of bone morphogenetic protein in comparison with autogenous bone in regeneration of ameloblastoma bone defects. A systematic review.骨形态发生蛋白在成釉细胞瘤骨缺损再生中与自体骨的疗效比较。系统评价。
Med Oral Patol Oral Cir Bucal. 2024 Nov 1;29(6):e782-e790. doi: 10.4317/medoral.26729.
2
Clinical application of bone morphogenetic proteins for bone healing: a systematic review.骨形态发生蛋白在骨愈合中的临床应用:一项系统评价。
Int Orthop. 2017 Jun;41(6):1073-1083. doi: 10.1007/s00264-017-3471-9. Epub 2017 Apr 19.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Human segmental mandibular defects treated with naturally derived bone morphogenetic proteins.采用天然来源骨形态发生蛋白治疗的人类节段性下颌骨缺损。
J Craniofac Surg. 2002 May;13(3):434-44. doi: 10.1097/00001665-200205000-00014.
5
Bone morphogenetic proteins and bone defects: a systematic review.骨形态发生蛋白与骨缺损:一项系统综述
Spine (Phila Pa 1976). 2007 Apr 1;32(7):824-30. doi: 10.1097/01.brs.0000259227.51180.ca.
6
Growth factors and bone regeneration: how much bone can we expect?生长因子与骨再生:我们能期望多少骨量的再生?
Injury. 2011 Jun;42(6):574-9. doi: 10.1016/j.injury.2011.03.034. Epub 2011 Apr 13.
7
Mandibular reconstruction with autologous human bone marrow stem cells and autogenous bone graft in a patient with plexiform ameloblastoma.一名丛状成釉细胞瘤患者采用自体人骨髓干细胞和自体骨移植进行下颌骨重建。
J Craniofac Surg. 2013 Jul;24(4):e409-11. doi: 10.1097/SCS.0b013e318292c91d.
8
The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review.骨替代移植物治疗牙周骨缺损的疗效:一项系统评价
Ann Periodontol. 2003 Dec;8(1):227-65. doi: 10.1902/annals.2003.8.1.227.
9
Off-label use of rhBMP-2 as bone regeneration strategies in mandibular ameloblastoma unicystic.重组人骨形态发生蛋白-2在下颌单囊性成釉细胞瘤中作为骨再生策略的非标签使用。
Einstein (Sao Paulo). 2017 Jan-Mar;15(1):92-95. doi: 10.1590/S1679-45082017RC3777.
10
Bone morphogenic protein: an elixir for bone grafting--a review.骨形态发生蛋白:骨移植的灵丹妙药——综述
J Oral Implantol. 2012 Dec;38(6):767-78. doi: 10.1563/AAID-JOI-D-10-00196. Epub 2011 May 16.

引用本文的文献

1
Development of biomaterials for bone tissue engineering based on bile acids.基于胆汁酸的骨组织工程生物材料的研发
J Mater Sci Mater Med. 2025 Jan 15;36(1):11. doi: 10.1007/s10856-024-06850-7.

本文引用的文献

1
Nonvascularized bone grafts: how successful are they in reconstruction of segmental mandibular defects?非血管化骨移植:在重建下颌骨节段性缺损方面的成功率如何?
Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 May;137(5):e63-e72. doi: 10.1016/j.oooo.2023.10.010. Epub 2023 Oct 29.
2
Ameloblastoma: An Updated Narrative Review of an Enigmatic Tumor.成釉细胞瘤:对一种神秘肿瘤的最新叙述性综述
Cureus. 2022 Aug 6;14(8):e27734. doi: 10.7759/cureus.27734. eCollection 2022 Aug.
3
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours.
《头颈部肿瘤第五版世界卫生组织分类更新:牙源性和颌骨肿瘤》。
Head Neck Pathol. 2022 Mar;16(1):63-75. doi: 10.1007/s12105-021-01404-7. Epub 2022 Mar 21.
4
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
5
Immediate Reconstruction of Segmental Mandibular Defects With Nonvascular Bone Grafts: A 30-Year Perspective.非血管化骨移植即刻重建节段性下颌骨缺损:30年回顾
J Oral Maxillofac Surg. 2020 Nov;78(11):2099.e1-2099.e9. doi: 10.1016/j.joms.2020.03.035.
6
Methodological quality of case series studies: an introduction to the JBI critical appraisal tool.病例系列研究的方法学质量:JBI 批判性评价工具介绍。
JBI Evid Synth. 2020 Oct;18(10):2127-2133. doi: 10.11124/JBISRIR-D-19-00099.
7
Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor.上颌骨造釉细胞瘤:一种罕见肿瘤的临床、组织学和预后数据的综述。
In Vivo. 2020 Sep-Oct;34(5):2249-2258. doi: 10.21873/invivo.12035.
8
Is Reconstruction of Large Mandibular Defects Using Bioengineering Materials Effective?使用生物工程材料重建大型下颌骨缺损是否有效?
J Oral Maxillofac Surg. 2020 Apr;78(4):661.e1-661.e29. doi: 10.1016/j.joms.2019.11.024. Epub 2019 Dec 2.
9
Nonvascularized Bone Grafts for Reconstruction of Segmental Mandibular Defects: Is Length of Graft a Factor of Success?用于节段性下颌骨缺损重建的非血管化骨移植:移植骨长度是成功的因素吗?
J Oral Maxillofac Surg. 2019 Dec;77(12):2557-2566. doi: 10.1016/j.joms.2019.05.008. Epub 2019 May 25.
10
Reconstruction of intercalary bone defect after resection of malignant bone tumor.恶性骨肿瘤切除术后节段性骨缺损的重建
J Orthop Surg (Hong Kong). 2019 Jan-Apr;27(1):2309499019832970. doi: 10.1177/2309499019832970.